Tiantao Gao

1.3k total citations
18 papers, 460 citations indexed

About

Tiantao Gao is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Tiantao Gao has authored 18 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Tiantao Gao's work include Epigenetics and DNA Methylation (4 papers), Cancer-related gene regulation (4 papers) and RNA modifications and cancer (3 papers). Tiantao Gao is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer-related gene regulation (4 papers) and RNA modifications and cancer (3 papers). Tiantao Gao collaborates with scholars based in China and United States. Tiantao Gao's co-authors include Qian Lei, Luoting Yu, Xuejiao Song, Yong Xia, Ningyu Wang, Tinghong Ye, Cuiting Peng, Zhanzhan Feng, Zhihao Liu and Yongxia Zhu and has published in prestigious journals such as Scientific Reports, RSC Advances and Cancer Letters.

In The Last Decade

Tiantao Gao

16 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tiantao Gao China	12	297	96	55	52	48	18	460
Hailin Liu China	15	257 0.9×	100 1.0×	70 1.3×	24 0.5×	95 2.0×	27	720
Faranak Fallahian Iran	15	371 1.2×	99 1.0×	38 0.7×	26 0.5×	124 2.6×	27	552
Rachana Trivedi India	8	388 1.3×	146 1.5×	38 0.7×	49 0.9×	98 2.0×	11	560
Lingmei Li China	15	385 1.3×	87 0.9×	52 0.9×	57 1.1×	90 1.9×	38	613
Changshan Yang China	13	362 1.2×	164 1.7×	50 0.9×	68 1.3×	54 1.1×	14	546
Jean‐François Gaussin Belgium	7	343 1.2×	114 1.2×	134 2.4×	36 0.7×	80 1.7×	10	587
Seung Yeob Hyun South Korea	13	264 0.9×	80 0.8×	38 0.7×	34 0.7×	82 1.7×	14	371
Yuzhu Zheng China	10	275 0.9×	129 1.3×	39 0.7×	47 0.9×	59 1.2×	15	450
Xiaoying Lan China	15	461 1.6×	227 2.4×	76 1.4×	63 1.2×	77 1.6×	20	699
David Martínez‐García Spain	6	271 0.9×	88 0.9×	23 0.4×	25 0.5×	65 1.4×	7	394

Countries citing papers authored by Tiantao Gao

Since Specialization

Citations

This map shows the geographic impact of Tiantao Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiantao Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiantao Gao more than expected).

Fields of papers citing papers by Tiantao Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiantao Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiantao Gao. The network helps show where Tiantao Gao may publish in the future.

Co-authorship network of co-authors of Tiantao Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Tiantao Gao. A scholar is included among the top collaborators of Tiantao Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiantao Gao. Tiantao Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Miao, Jia, Zhenling Wang, Zhenyu Ding, et al.. (2025). Safety, Tolerability, and Pharmacokinetics of a Novel Nitroimidazooxazole Antitubercular Agent in Healthy Adults: A Phase I Trial. MedComm. 6(12). e70510–e70510.

Gao, Tiantao, et al.. (2024). Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study. Bioanalysis. 16(23-24). 1229–1240.

Xu, Ying, Zhihao Liu, Lifeng Zhao, et al.. (2020). Novel Dual BET and PLK1 Inhibitor WNY0824 Exerts Potent Antitumor Effects in CRPC by Inhibiting Transcription Factor Function and Inducing Mitotic Abnormality. Molecular Cancer Therapeutics. 19(6). 1221–1231. 16 indexed citations

Xue, Qiang, Zhihao Liu, Zhanzhan Feng, et al.. (2019). Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis. Biomedicine & Pharmacotherapy. 121. 109598–109598. 23 indexed citations

Feng, Qiang, Tiantao Gao, Qiangsheng Zhang, et al.. (2019). Synthesis and biological evaluation of benzomorpholine derivatives as novel EZH2 inhibitors for anti-non-small cell lung cancer activity. Molecular Diversity. 23(3). 681–696. 6 indexed citations

Song, Xuejiao, Tiantao Gao, Qian Lei, et al.. (2018). Piperlongumine Induces Apoptosis in Human Melanoma Cells Via Reactive Oxygen Species Mediated Mitochondria Disruption. Nutrition and Cancer. 70(3). 502–511. 35 indexed citations

Gao, Tiantao, Xi Hu, Qian Lei, et al.. (2018). Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis. Cancer Letters. 445. 11–23. 32 indexed citations

Gao, Tiantao, Yao Shi, Qian Lei, et al.. (2018). Design, synthesis and biological evaluation of novel 1-phenyl phenanthridin-6(5H)-one derivatives as anti-tumor agents targeting TOPK. European Journal of Medicinal Chemistry. 162. 407–422. 15 indexed citations

Lei, Qian, Lu Xiong, Yong Xia, et al.. (2018). YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect. Cell Death and Disease. 9(11). 1066–1066. 48 indexed citations

10.

Feng, Zhanzhan, Yong Xia, Tiantao Gao, et al.. (2018). The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis. Cell Death and Disease. 9(10). 1006–1006. 68 indexed citations

11.

Gao, Tiantao, et al.. (2018). Palladium-catalyzed intramolecular C–H arylation of 2-halo-N-Boc-N-arylbenzamides for the synthesis of N–H phenanthridinones. RSC Advances. 8(25). 13879–13890. 11 indexed citations

12.

Xiong, Menghua, Qian Lei, Xinyu You, et al.. (2017). Mannosylated liposomes improve therapeutic effects of paclitaxel in colon cancer models. Journal of Microencapsulation. 34(6). 513–521. 40 indexed citations

13.

Zhu, Yongxia, Tinghong Ye, Xi Yu, et al.. (2016). Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. Scientific Reports. 6(1). 20253–20253. 64 indexed citations

14.

Song, Xuejiao, Tiantao Gao, Ningyu Wang, et al.. (2016). Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer. Scientific Reports. 6(1). 20864–20864. 50 indexed citations

15.

Song, Xuejiao, Lidan Zhang, Tiantao Gao, et al.. (2016). Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation. Biomedicine & Pharmacotherapy. 81. 288–294. 23 indexed citations

16.

Deng, Hongxia, Jun Zeng, Yongxia Zhu, et al.. (2016). A novel small-molecule YLT256 inhibits proliferation and induces apoptosis both in vitro and in vivo in solid tumors. Biomedicine & Pharmacotherapy. 81. 482–490. 1 indexed citations

17.

Gao, Tiantao, Lidan Zhang, Yongxia Zhu, et al.. (2016). ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth. RSC Advances. 6(34). 28512–28521. 10 indexed citations

18.

Zhang, Lidan, Xuejiao Song, Ningyu Wang, et al.. (2015). Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors. RSC Advances. 5(33). 25967–25978. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact